Biological Therapies in Cancer Treatment to Reach $66 Billion in 2019; Biosimilars Proving to be a Major Driving Factor

Biological Therapies in Cancer Treatment to Reach $66 Billion in 2019; Biosimilars Proving to be a Major Driving Factor
Wellesley, Mass. (PRWEB) March 24, 2015 Wellesley, Mass., March 24, 2015 – BCC Research (http://www.bccresearch.com) reveals in its new report on biologic cancer treatment that access and affordability of cancer treatment options in various countries, along with a rise in the number of cancer incidences due to better diagnostic approaches, will stimulate growth in the ...

Biological Therapies in Cancer Treatment to Reach $66 Billion in 2019; Biosimilars Proving to be a Major Driving Factor

Biological Therapies in Cancer Treatment to Reach $66 Billion in 2019; Biosimilars Proving to be a Major Driving Factor
Wellesley, Mass. (PRWEB) March 24, 2015 Wellesley, Mass., March 24, 2015 – BCC Research (http://www.bccresearch.com) reveals in its new report on biologic cancer treatment that access and affordability of cancer treatment options in various countries, along with a rise in the number of cancer incidences due to better diagnostic approaches, will stimulate growth in the ...